NODELMAN OLEG
Insider CIK 1454385 · ANAB Director, 10% owner · KIN Director · NUVB CEO and Chairman of the Board, Director, 10% owner · PANA CEO and Chairman of the Board, Director, 10% owner · ZYME Director, 10% owner · AKTS Director · GNVC 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 102,500 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 86,222 | — | $0 | 86,222 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 965,190 | — | $0 | 965,190 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 2,397,500 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 488,891 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 997,299 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 9,913,810 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | P Buy | 2026-01-12 | 2026-01-12 | 144,443 | $18.00 | $2.60M | 347,305 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-12 | 2,270,879 | — | $0 | 2,270,879 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-12 | 202,862 | — | $0 | 202,862 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-12 | 128,506 | — | $0 | 128,506 | SEC↗ |
| AKTS Aktis Oncology, Inc. | P Buy | 2026-01-12 | 2026-01-12 | 2,077,779 | $18.00 | $37.40M | 4,348,658 | SEC↗ |
| ZYME Zymeworks Inc. | X Exercise deriv | 2025-06-26 | 2025-06-27 | 5,086,521 | — | $0 | 0 | SEC↗ |
| ZYME Zymeworks Inc. | F Tax w/h | 2025-06-26 | 2025-06-27 | 41 | $12.71 | $521 | 22,970,388 | SEC↗ |
| ZYME Zymeworks Inc. | X Exercise | 2025-06-26 | 2025-06-27 | 5,086,480 | — | $0 | 22,970,388 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-05-19 | 2025-05-19 | 5,919 | $11.78 | $69.7K | 17,883,908 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-05-15 | 2025-05-19 | 49,502 | $11.43 | $565.8K | 17,877,989 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-04-17 | 2025-04-18 | 54,760 | $11.52 | $630.8K | 17,828,487 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-04-16 | 2025-04-18 | 73,953 | $11.16 | $825.3K | 17,773,727 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-04-04 | 2025-04-07 | 196,438 | $11.17 | $2.19M | 17,699,774 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-04-03 | 2025-04-07 | 120,770 | $11.84 | $1.43M | 17,503,336 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-04-02 | 2025-04-02 | 74,360 | $11.85 | $881.2K | 17,382,566 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-04-01 | 2025-04-02 | 48,658 | $11.60 | $564.4K | 17,308,206 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-31 | 2025-04-02 | 4,397 | $11.75 | $51.7K | 17,259,548 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-26 | 2025-03-27 | 43,848 | $12.24 | $536.7K | 17,255,151 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-25 | 2025-03-27 | 53,501 | $12.91 | $690.7K | 17,211,303 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-24 | 2025-03-24 | 22,689 | $13.08 | $296.8K | 17,157,802 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-21 | 2025-03-24 | 31,033 | $12.78 | $396.6K | 17,135,113 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-20 | 2025-03-24 | 73,476 | $12.93 | $950.0K | 17,104,080 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-19 | 2025-03-19 | 58,306 | $12.64 | $737.0K | 17,030,604 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-18 | 2025-03-19 | 113,880 | $12.65 | $1.44M | 16,972,298 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-17 | 2025-03-19 | 56,277 | $12.23 | $688.3K | 16,858,418 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-13 | 2025-03-13 | 468,356 | $12.48 | $5.85M | 16,802,141 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-12 | 2025-03-13 | 292,934 | $12.25 | $3.59M | 16,333,785 | SEC↗ |
| ZYME Zymeworks Inc. | P Buy | 2025-03-11 | 2025-03-13 | 320,690 | $11.49 | $3.68M | 16,040,851 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2025-01-02 | 2025-01-02 | 6,646 | $12.95 | $86.1K | 7,880,094 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2024-12-31 | 2025-01-02 | 13,268 | $12.93 | $171.6K | 7,873,448 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2024-12-30 | 2025-01-02 | 65,184 | $12.92 | $842.2K | 7,860,180 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2023-09-21 | 2023-09-22 | 53,000 | $1.36 | $72.1K | 12,674,775 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2023-09-20 | 2023-09-22 | 117,100 | $1.36 | $159.3K | 12,621,775 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2023-09-19 | 2023-09-22 | 5,143,000 | $1.26 | $6.48M | 12,504,675 | SEC↗ |
| PANA Panacea Acquisition Corp. | D To issuer | 2023-04-28 | 2023-05-02 | 545,000 | — | $0 | 0 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2023-02-21 | 2023-09-21 | 53,000 | $1.36 | $72.1K | 12,674,775 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2023-02-20 | 2023-09-21 | 117,100 | $1.36 | $159.3K | 12,621,775 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2023-02-19 | 2023-09-21 | 5,143,000 | $1.26 | $6.48M | 12,504,675 | SEC↗ |
| ANAB ANAPTYSBIO, INC | S Sale | 2022-05-05 | 2022-05-09 | 668,237 | $21.63 | $14.45M | 7,521,024 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2022-05-05 | 2022-05-09 | 668,237 | $21.63 | $14.45M | 7,521,024 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-11-24 | 2021-11-30 | 21,758 | $7.69 | $167.3K | 1,169,241 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-11-24 | 2021-11-30 | 163,268 | $7.69 | $1.26M | 7,361,675 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2021-10-29 | 2021-11-02 | 45,229 | — | $0 | 45,229 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-07-31 | 2021-11-30 | 56,598 | $8.64 | $489.0K | 7,198,407 | SEC↗ |
| NUVB Nuvation Bio Inc. | S Sale | 2021-07-31 | 2021-11-30 | 56,598 | $8.64 | $489.0K | 1,147,483 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-05-04 | 2021-05-04 | 165,000 | $23.25 | $3.84M | 7,520,424 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-05-03 | 2021-05-04 | 20,800 | $23.31 | $484.8K | 7,355,424 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-04-30 | 2021-05-04 | 35,700 | $23.16 | $826.8K | 7,334,624 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-04-27 | 2021-04-27 | 33,800 | $23.82 | $805.1K | 7,298,924 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-04-26 | 2021-04-27 | 13,900 | $23.80 | $330.8K | 7,265,124 | SEC↗ |
| ANAB ANAPTYSBIO, INC | P Buy | 2021-04-23 | 2021-04-27 | 99,600 | $23.54 | $2.34M | 7,251,224 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-04-13 | 2021-04-13 | 27,534 | $10.27 | $282.8K | 6,990,265 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-04-13 | 2021-04-13 | 3,966 | $10.27 | $40.7K | 1,355,625 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-04-12 | 2021-04-13 | 116,255 | $9.49 | $1.10M | 6,962,731 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-04-12 | 2021-04-13 | 16,745 | $9.49 | $158.9K | 1,351,659 | SEC↗ |
| PANA Panacea Acquisition Corp. | P Buy | 2021-04-09 | 2021-04-13 | 545,000 | $10.00 | $5.45M | 545,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-04-09 | 2021-04-13 | 37,770 | $10.03 | $378.8K | 1,334,914 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-04-09 | 2021-04-13 | 262,230 | $10.03 | $2.63M | 6,846,476 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2021-03-31 | 2021-11-30 | 151,544 | $10.45 | $1.58M | 6,735,790 | SEC↗ |
| NUVB Nuvation Bio Inc. | S Sale | 2021-03-31 | 2021-11-30 | 151,544 | $10.45 | $1.58M | 1,145,600 | SEC↗ |
| NUVB Nuvation Bio Inc. | C Conversion deriv | 2021-02-10 | 2021-02-12 | 2,775,000 | — | $0 | 0 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 702,000 | — | $0 | 702,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 131,333 | — | $0 | 131,333 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 130,000 | — | $0 | 130,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 2,365,511 | — | $0 | 6,584,246 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 387,265 | $10.00 | $3.87M | 781,265 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 2,112,735 | $10.00 | $21.13M | 4,218,735 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 2,200,627 | — | $0 | 2,200,627 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 2,106,000 | — | $0 | 2,106,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | C Conversion | 2021-02-10 | 2021-02-12 | 2,775,000 | — | $0 | 3,165,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 515,879 | — | $0 | 1,297,144 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award | 2021-02-10 | 2021-02-12 | 394,000 | — | $0 | 394,000 | SEC↗ |
| PANA Panacea Acquisition Corp | P Buy | 2020-07-06 | 2020-07-06 | 390,000 | $10.00 | $3.90M | 390,000 | SEC↗ |
| KIN Kindred Biosciences, Inc. | P Buy | 2014-09-29 | 2014-09-30 | 55,590 | $9.56 | $531.4K | 614,495 | SEC↗ |
| KIN Kindred Biosciences, Inc. | P Buy | 2014-09-29 | 2014-09-30 | 44,410 | $9.56 | $424.6K | 490,936 | SEC↗ |
| KIN Kindred Biosciences, Inc. | P Buy | 2014-08-28 | 2014-08-29 | 13,720 | $10.98 | $150.6K | 551,793 | SEC↗ |
| KIN Kindred Biosciences, Inc. | P Buy | 2014-08-28 | 2014-08-29 | 11,280 | $10.98 | $123.9K | 453,638 | SEC↗ |
| KIN Kindred Biosciences, Inc. | P Buy | 2014-08-27 | 2014-08-29 | 9,927 | $10.70 | $106.2K | 442,358 | SEC↗ |
| KIN Kindred Biosciences, Inc. | P Buy | 2014-08-27 | 2014-08-29 | 12,073 | $10.70 | $129.2K | 538,073 | SEC↗ |
| KIN Kindred Biosciences, Inc. | P Buy | 2014-08-26 | 2014-08-27 | 18,847 | $10.51 | $198.1K | 517,323 | SEC↗ |
| KIN Kindred Biosciences, Inc. | P Buy | 2014-08-26 | 2014-08-27 | 15,497 | $10.51 | $162.9K | 441,108 | SEC↗ |
| KIN Kindred Biosciences, Inc. | P Buy | 2014-08-25 | 2014-08-27 | 27,933 | $10.49 | $293.0K | 498,476 | SEC↗ |
| KIN Kindred Biosciences, Inc. | P Buy | 2014-08-25 | 2014-08-27 | 22,967 | $10.49 | $240.9K | 425,611 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-05-27 | 2014-05-27 | 4,662 | $2.39 | $11.1K | 1,024,358 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-05-27 | 2014-05-27 | 4,378 | $2.39 | $10.5K | 962,055 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-05-23 | 2014-05-27 | 2,372 | $2.19 | $5.2K | 1,019,696 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-05-23 | 2014-05-27 | 2,228 | $2.19 | $4.9K | 957,677 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-05-22 | 2014-05-27 | 5,085 | $2.13 | $10.8K | 955,449 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-05-22 | 2014-05-27 | 5,415 | $2.13 | $11.5K | 1,017,324 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-03-28 | 2014-03-28 | 19,006 | $2.73 | $51.9K | 785,366 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-03-28 | 2014-03-28 | 28,509 | $2.73 | $77.8K | 1,176,907 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-03-27 | 2014-03-28 | 30,729 | $2.49 | $76.5K | 1,148,398 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-03-27 | 2014-03-28 | 20,486 | $2.49 | $51.0K | 766,360 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-03-26 | 2014-03-28 | 9,417 | $2.31 | $21.8K | 745,874 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-03-26 | 2014-03-28 | 14,126 | $2.31 | $32.6K | 1,117,669 | SEC↗ |
| KIN Kindred Biosciences, Inc. | A Award deriv | 2014-02-03 | 2014-02-05 | 35,500 | — | $0 | 35,500 | SEC↗ |
| KIN Kindred Biosciences, Inc. | P Buy | 2013-12-12 | 2013-12-13 | 400,000 | $7.00 | $2.80M | 873,187 | SEC↗ |
| KIN Kindred Biosciences, Inc. | A Award deriv | 2013-12-11 | 2013-12-13 | 20,000 | — | $0 | 20,000 | SEC↗ |